Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection
Adamek, R.J.; Opferkuch, W.; Wegener, M.
American Journal of Gastroenterology 90(1): 168-169
1995
ISSN/ISBN: 0002-9270 PMID: 7801936 Document Number: 442509
Document emailed within 1 workday
Related Documents
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602Fattahi, E.; Motamedi, R.; Nayebi, A.R.M.; Rezazadeh, H.; Shakir, A. 2004: Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(4): 154
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Chey, W.D.; Fisher, L.; Elta, G.H.; Barnett, J.L.; Nostrant, T.; DelValle, J.; Hasler, W.L.; Scheiman, J.M. 1997: Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial American Journal of Gastroenterology 92(9): 1483-1486
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059
Schepp, W. 1995: Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori Zeitschrift für Gastroenterologie 33(10): 621-623
Frotz, H.; Ahrends, H.; Hebbeln, H.; Klass, D.; Miederer, S.E.; Mittelstaedt, A.; Rolfs, H.C.; von Geldern, R. 1995: Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer Arzneimittel-Forschung 45(2): 184-186
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Duggan, A.; Williamson, R. 1998: Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori Gut 42(4): 596-597
Dorval, E.D.; Loulergue, J.; Barbieux, J.P.; Metman, E.H.; de Muret, A. 1991: Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy Gastroenterologie Clinique et Biologique 15(11): 863-864
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Cui, M.; Hu, F.; Jiang, H.; Zheng, X. 2002: Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection Zhonghua Yi Xue Za Zhi 82(18): 1245-1248
Marini, R.P.; Fox, J.G.; Taylor, N.S.; Yan, L.; McColm, A.A.; Williamson, R. 1999: Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets American Journal of Veterinary Research 60(10): 1280-1286
Shirai, N.; Furuta, T. 2002: High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 2: 439-444
al-Assi, M.T.; Cole, R.A.; Karttunen, T.J.; el-Zimaity, H.; Genta, R.M.; Graham, D.Y. 1995: Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin American Journal of Gastroenterology 90(9): 1411-1414
Zheng, X.-L.; Hu, F.-L.; Wang, W.-H.; Xu, L. 2009: Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains Zhonghua Yi Xue Za Zhi 89(22): 1558-1562
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Treiber, G.; Wittig, J.; Ammon, S.; Walker, S.; van Doorn, L-Jan.; Klotz, U. 2002: Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study) Archives of Internal Medicine 162(2): 153-160
Sanfélix Genovés, J.; Pereiró Berenguer, I.; Jimeno Bernard, R.; García Tell, G.; Navarro Pérez, J.; Bonet Pla, A.; Ballester Belenguer, J. 1998: Helicobacter pylori: 6-day triple therapy in duodenal ulcer Atencion Primaria 21(8): 517-521